SUNITINIB MALATE AS MAINTENANCE THERAPY IN PATIENTS (PTS) WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY

被引：0
|
作者：
Blais, N. [1 ]
Page, R. [2 ]
Hainsworth, J. [3 ]
Soria, J. [4 ]
Laskin, J. [5 ]
Hamm, J. T. [6 ]
Selaru, P. [7 ]
Kim, S. T. [7 ]
Chao, R. [7 ]
Gervais, R. [8 ]
机构：
[1] CHUM Hop Notre Dame, Montreal, PQ, Canada
[2] Ctr Canc & Blood Disorders, Ft Worth, TX USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Inst Gustave Roussy, Villejuif, France
[5] BC Canc Agcy, Vancouver, BC, Canada
[6] Norton Canc Inst, Louisville, KY USA
[7] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
[8] Oncol Inst F Baclesse Ctr, Caen, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Phase II study of sunitinib malate (SU) as consolidation therapy in patients (pts) with locally-advanced or metastatic non-small cell lung cancer (NSCLC)
    Gervais, R.
    Hainsworth, J. D.
    Blais, N.
    Soria, J. C.
    Laskin, J.
    Hamm, J. T.
    Lipton, A.
    Tye, L.
    Chao, R.
    Page, R. D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 372 - 372
  • [2] Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer
    Gervais, Radj
    Hainsworth, John D.
    Blais, Normand
    Besse, Benjamin
    Laskin, Janessa
    Hamm, John T.
    Lipton, Allan
    Albain, Kathy S.
    Masters, Gregory A.
    Natale, Ronald B.
    Selaru, Paulina
    Kim, Sindy T.
    Chao, Richard C.
    Page, Ray D.
    LUNG CANCER, 2011, 74 (03) : 474 - 480
  • [3] Gemcitabine in locally advanced and metastatic non-small cell lung cancer (NSCLC): The Central European phase II study
    Jassem, J
    Zatloukal, P
    Kanitz, E
    Magyar, P
    Krzakowski, M
    Pawlicki, M
    Petruzelka, L
    Chovan, L
    Pesek, M
    Krejcy, K
    ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [4] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in patients (pts) with locally advanced non-small cell lung cancer (NSCLC)
    Aerts, J
    van Klaveren, R
    Surmont, V
    Senan, S
    Tan, Y
    Vernhout, R
    van Wijhe, G
    Verhoeven, G
    Hoogsteden, H
    van Meerbeeck, J
    LUNG CANCER, 2005, 49 : S164 - S164
  • [5] Health-related quality of life (HRQOL) with sunitinib (SU) as maintenance therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Blais, Normand
    Torigoe, Yasuhiro
    Luo Yingchun
    Wei, Greg C.
    Cappelleri, Joseph C.
    Kim, Sindy T.
    Chao, Richard
    Goss, Glenwood
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S667 - S667
  • [6] A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Lind, J. S.
    Dingemans, A. C.
    Groen, H. J.
    Smit, E. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Lind, Joline S.
    Dingemans, Anne-Marie C.
    Groen, Harry J.
    Smit, Egbert F.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S412 - S413
  • [8] Sunitinib in Combination With Erlotinib for the Treatment of Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC): a Phase III Study
    Govindan, R.
    Krzakowski, M. J.
    Szczesna, A.
    Strausz, J.
    Makhson, A. N.
    Reck, M.
    Tye, L.
    Zhang, K.
    Chao, R. C.
    Scagliotti, G. V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S557 - S557
  • [9] ACTIVITY OF PATUPILONE IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Zatloukal, P.
    Mellemgaard, A.
    Sanchez, J. M.
    Perry, M. C.
    Hamm, J. T.
    Van Meerbeeck, J.
    DeLeo, J. J.
    Gao, B.
    Johri, A. R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [10] Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer
    Boyer, MJ
    Mitchell, P
    Goldstein, D
    Millward, MJ
    Olver, IN
    Clarke, SJ
    Richardson, G
    Davis, I
    LUNG CANCER, 2001, 32 (01) : 89 - 94
12345